Director at Option Care Health (OPCH) receives 8,997 RSUs worth $200,000

Rhea-AI Filing Summary

Wright Norman L. reported acquisition or exercise transactions in this Form 4 filing.

Option Care Health, Inc. director Norman L. Wright reported an equity award rather than a market trade. On May 20, 2026, he received 8,997 restricted stock units, designed to reflect $200,000 of value based on that day’s closing share price. These units vest in full on May 20, 2027, meaning he must remain eligible through that date to receive all shares. Following this award, Wright directly holds 24,498 shares of the company’s common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Wright Norman L.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,997	$0.00	--

Holdings After Transaction: Common Stock — 24,498 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 8,997 shares Grant value: $200,000 Vesting date: May 20, 2027 +1 more

4 metrics

RSUs granted 8,997 shares Restricted stock units awarded on May 20, 2026

Grant value $200,000 Value based on closing price on May 20, 2026

Vesting date May 20, 2027 Restricted stock units vest in full on this date

Shares after transaction 24,498 shares Total common stock directly held following the award

Key Terms

restricted stock units, vest in full, closing price, Grant, award, or other acquisition

4 terms

restricted stock units financial

"The reporting person received an award of restricted stock units on May 20, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest in full financial

"which vest in full on May 20, 2027"

closing price financial

"based on the closing price of the issuer's common stock on May 20, 2026"

Grant, award, or other acquisition financial

"transaction code description shows Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wright Norman L.

(Last) (First) (Middle)

C/O OPTION CARE HEALTH, INC.

3000 LAKESIDE DRIVE, SUITE 300N

(Street)

BANNOCKBURN ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/20/2026		A		8,997(1)	A	$0	24,498	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received an award of restricted stock units on May 20, 2026, which vest in full on May 20, 2027. The number of restricted stock units granted was calculated to reflect $200,000 of value based on the closing price of the issuer's common stock on May 20, 2026.

	/s/ Michael Bavaro, attorney-in-fact for Mr. Wright	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Option Care Health (OPCH) disclose for Norman L. Wright?

Option Care Health disclosed that director Norman L. Wright received an equity award, not an open-market trade. He was granted 8,997 restricted stock units on May 20, 2026, as compensation, based on a target value of $200,000 using that day’s closing share price.

How large is Norman L. Wright’s new equity grant at Option Care Health (OPCH)?

The grant to director Norman L. Wright totals 8,997 restricted stock units. The number of units was calculated to represent $200,000 of value, using the closing price of Option Care Health’s common stock on May 20, 2026, as described in the filing footnote.

When do Norman L. Wright’s Option Care Health (OPCH) restricted stock units vest?

Norman L. Wright’s restricted stock units vest in full on May 20, 2027. Vesting means the units convert into shares he can actually own, assuming he satisfies any continued service or eligibility conditions through that one-year vesting period described in the award terms.

Did Norman L. Wright buy or sell Option Care Health (OPCH) shares in the market?

He did not buy or sell shares in the open market. The Form 4 reports a compensation-related grant coded as an acquisition (code A), where 8,997 restricted stock units were awarded at no cash cost per share rather than through a purchase or sale transaction.

How many Option Care Health (OPCH) shares does Norman L. Wright hold after this grant?

After the reported grant, Norman L. Wright directly holds 24,498 shares of Option Care Health common stock. This total reflects his position following the addition of 8,997 restricted stock units reported in the Form 4, as summarized in the transaction details section.